KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.0511 $0.0700 Thursday, 25th Apr 2024 BLPH stock ended at $0.0550. This is 1.66% more than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 0.92% from a day low at $0.0545 to a day high of $0.0550.
90 days $0.0470 $0.0700
52 weeks $0.0290 $11.15

Historical Bellerophon Therapeutics prices

Date Open High Low Close Volume
Apr 25, 2024 $0.0545 $0.0550 $0.0545 $0.0550 10 136
Apr 24, 2024 $0.0522 $0.0612 $0.0522 $0.0541 47 039
Apr 23, 2024 $0.0586 $0.0586 $0.0586 $0.0586 5 012
Apr 22, 2024 $0.0516 $0.0553 $0.0511 $0.0511 2 320
Apr 19, 2024 $0.0542 $0.0600 $0.0542 $0.0544 53 937
Apr 18, 2024 $0.0572 $0.0572 $0.0571 $0.0571 1 752
Apr 17, 2024 $0.0545 $0.0545 $0.0545 $0.0545 1 159
Apr 16, 2024 $0.0550 $0.0571 $0.0541 $0.0545 4 525
Apr 15, 2024 $0.0535 $0.0571 $0.0535 $0.0571 10 319
Apr 12, 2024 $0.0562 $0.0568 $0.0536 $0.0550 3 304
Apr 11, 2024 $0.0561 $0.0600 $0.0523 $0.0531 21 466
Apr 10, 2024 $0.0600 $0.0600 $0.0550 $0.0600 12 555
Apr 09, 2024 $0.0618 $0.0618 $0.0600 $0.0600 5 170
Apr 08, 2024 $0.0541 $0.0605 $0.0521 $0.0527 1 508
Apr 05, 2024 $0.0543 $0.0700 $0.0543 $0.0550 205 112
Apr 04, 2024 $0.0541 $0.0542 $0.0541 $0.0542 53 912
Apr 03, 2024 $0.0540 $0.0566 $0.0540 $0.0542 2 530
Apr 02, 2024 $0.0590 $0.0590 $0.0530 $0.0531 45 872
Apr 01, 2024 $0.0551 $0.0590 $0.0512 $0.0556 10 528
Mar 28, 2024 $0.0568 $0.0568 $0.0568 $0.0568 0
Mar 27, 2024 $0.0541 $0.0568 $0.0541 $0.0568 1 066
Mar 26, 2024 $0.0542 $0.0577 $0.0542 $0.0577 4 727
Mar 25, 2024 $0.0540 $0.0599 $0.0540 $0.0599 15 284
Mar 22, 2024 $0.0512 $0.0600 $0.0512 $0.0550 188 899
Mar 21, 2024 $0.0512 $0.0556 $0.0512 $0.0556 25 391
Click to get the best stock tips daily for free!

About Bellerophon Therapeutics

Bellerophon Therapeutics Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w... BLPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT